Xiamen, China

Zaiyou Yang

This inventor holds 1 USPTO granted patent. Top assignee: Xiamen University. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zaiyou Yang: Innovator in Pharmaceutical Compounds

Introduction

Zaiyou Yang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of tumors. His work is characterized by a focus on innovative chemical formulations and their applications in medicine.

Latest Patents

Zaiyou Yang holds a patent for a substituted aryl ether compound, which includes a preparation method, pharmaceutical composition, and its use in medical applications. The patent describes a compound with a specific formula, including its stereoisomers, prodrugs, pharmaceutically acceptable salts, and solvates. This invention is particularly relevant for its potential use in manufacturing medicaments aimed at preventing or treating tumors.

Career Highlights

Zaiyou Yang is affiliated with Xiamen University, where he engages in research and development in the pharmaceutical sciences. His work has led to advancements in the understanding and application of chemical compounds in medicine. His innovative approach has garnered attention in the scientific community.

Collaborations

Zaiyou Yang has collaborated with notable colleagues, including Xianming Deng and Ting Zhang. These partnerships have contributed to the advancement of research in their respective fields and have fostered a collaborative environment for innovation.

Conclusion

Zaiyou Yang's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for serious health conditions. His work continues to inspire advancements in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…